iqvia semaglutide tirzepatide prescriptions us q3 2024 Are Up, Health Services Utilization Down, and GLP-1s Are a Major Growth Driver: IQVIA's Update Prescription trends for obesity medications

Endocr Relat Cancer 18:181192 Krner M, Stckli M, Waser B, Reubi JC (2007) GLP-1 receptor expression in human tumors and human normal tissues: potential for in vivo targeting

Don't forget about movement

Accessed 2 Sep 2023 Shamriz O, NaserEddin A, Mosenzon O, Sviri S, Tal Y (2019) Allergic reaction to exenatide and lixisenatide but not to liraglutide: unveiling anaphylaxis to glucagon-like peptide 1 receptor agonists

We performed this subgroup analysis for two reasons: 1) to eliminate the potentially confounding factor of using other diabetic medications such as metformin or insulin, and 2) we did not have data on the severity of diabetes such as hemoglobin A1c which may be an additional confounding factor